期刊文献+

端粒酶和端粒酶逆转录酶在胃癌组织中的表达及临床意义 被引量:2

Expression and clinical significance of telomerase and telomerase reverse transcriptase in gastric carcinomas
暂未订购
导出
摘要 目的探讨端粒酶和端粒酶逆转录酶(hTERT)在胃黏膜癌变过程中的作用及其过度表达与胃癌恶性病理生物学行为之间的关系。方法采用聚合酶链反应端粒酶重复序列扩增酶联免疫吸附测定法和免疫组化链菌素亲物蛋白过氧化酶法分别检测端粒酶和TERT在胃癌组织和癌旁非癌组织中的表达,计算阳性细胞的百分率。结果65例胃癌组织中,端粒酶和hTERT蛋白阳性表达率分别为86.2%和81.5%,显著高于相应癌旁非癌组织(P<0.01)。端粒酶活性表达与胃癌组织的淋巴结转移及PTNM分期显著相关(P<0.05),hTERT的表达和肿瘤浸润深度、淋巴结转移和PTNM分期显著相关(P<0.05)。结论检测端粒酶和hTERT可以帮助判断胃癌的发生、浸润、转移和临床分期。 Objective To explore the roles and relationships of telomerase and telomerase reverse transcriptase (TERT) in carciomgenesis of gastric cancer. Methods The telomerase activity and TERT protein in gastric cancer tissues and matched normal adjacent tissues were determined by PCR TRAP-ELISA assay and SP immunohistochemical staining assay,and percentage of positve rate was evaluated. Results Positive rate of telomerase and TERT protein in 65 gastric cancer tissues were, significantly higher than these of matched normal adjacent tissues( 86.2% and 81.5%, P〈0.01). Significant correlation was found between either lymph node metastasis or PTNM stage and telomerase activity in gastric cancer. The TERT overexpression correlated with tumor invasion, tumor infiltration depth, lymph node metastasis, and PTNM classification. Conclusion The detection of telomerase and TERT protein will help evaluate carcinogenesis, infiltration, metastasis and clinical stage of gastric cancer.
出处 《临床荟萃》 CAS 2010年第4期299-301,共3页 Clinical Focus
关键词 胃肿瘤 聚合酶链反应 端粒酶逆转录酶 淋巴结 gastric carcinoma polymerase chain reaction telomerase reverse transcriptase lymph node
  • 相关文献

参考文献4

二级参考文献11

共引文献21

同被引文献32

  • 1张赟,伍冬梅,李春鸣.端粒酶逆转录酶蛋白及mRNA在胃癌中的表达及相关性研究[J].贵州医药,2011,35(3):211-214. 被引量:4
  • 2左明,吴俊辉,刘宝善,刘超,徐琳.结直肠癌端粒酶活性检测及其对预后判断的意义[J].广东医学,2007,28(8):1252-1253. 被引量:7
  • 3Wu Q, Moyana T,Xiang J. Cancer gene therapy by adeno- virus-mediated gene transfer[J]. Curr Gene Ther, 2001,1 (1) :101-122.
  • 4Liu TC,Galanis E, Kirn D. Clinical trial results with on- colytic virotherapy..a century of promise,a decade of pro- gress[J]. Nat Clin Pract Oncol,2007,4(2) : 101-117.
  • 5Qian Q J, Jonathan S, Che XY, et al. Gene-vial vectors: a promising way to target tumor cells and express antican- cer genes simultaneously[J]. Chin Med J, 2002,115 (8) : 1213-1217.
  • 6Su CQ,Sham J, Xue HB, et al. Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting te- lomerase-positive cancer cells[J]. Cancer Res Clin Oncol, 2004,130 (10) : 591-603.
  • 7Martuza RL, Maliek A, Markert JM, et al. Experimental therapy of human glioma by means of a genetically engi- neered virus mutant[J]. Science, 1991,252 : 854-856.
  • 8Yamamoto M,Curiel DT. Current issues and future direc- tions of oncolytic adenoviruses[J]. Mol Ther, 2010, 18 (2):243-250.
  • 9Toth K, Dhar D, Wold WS. Oncolytic (replication-compe- tent) adenoviruses as anticaneer agents[J]. Expert Open Biol Ther, 2010,10 (3) : 353-368.
  • 10Herndndez-Alcoeeba R. Recent advances in oncolytic virus design[J]. Clin Transl Oncol,2011,13(4) :229-239.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部